Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Olsen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|December 18, 2007
A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)Peter F Gavin, Bernard A Olsen
Advanced Drug Delivery Reviews|December 27, 2006
Strategies for the investigation and control of process-related impurities in drug substancesMark D Argentine, Paul K Owens, Bernard A Olsen
Journal of Pharmaceutical and Biomedical Analysis|June 2, 2007
Is HPLC assay for drug substance a useful quality control attribute?Jeffrey D Hofer, Bernard A Olsen, Eugene C Rickard
Journal of Pharmaceutical and Biomedical Analysis|April 20, 2006
A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materialsPeter F Gavin, Bernard A Olsen, David D Wirth, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 15, 2006
Determination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phasesJane A Sellers, Bernard A Olsen, Paul K Owens, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2016
Formation of copper(I) from trace levels of copper(II) as an artifactual impurity in the HPLC analysis of olanzapineSteven W Baertschi, Bernard A Olsen, Timothy J Wozniak, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2009
A simple and efficient approach to reversed-phase HPLC method screeningKallol M Biswas, Bryan C Castle, Bernard A Olsen, et al.
Talanta|April 21, 2009
A new statistical method for the automated detection of peaks in UV-DAD chromatograms of a sample mixtureBenjamin Debrus, Pierre Lebrun, Attilio Ceccato, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|December 18, 2007
A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)Peter F Gavin, Bernard A Olsen
Advanced Drug Delivery Reviews|December 27, 2006
Strategies for the investigation and control of process-related impurities in drug substancesMark D Argentine, Paul K Owens, Bernard A Olsen
Journal of Pharmaceutical and Biomedical Analysis|June 2, 2007
Is HPLC assay for drug substance a useful quality control attribute?Jeffrey D Hofer, Bernard A Olsen, Eugene C Rickard
Journal of Pharmaceutical and Biomedical Analysis|April 20, 2006
A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materialsPeter F Gavin, Bernard A Olsen, David D Wirth, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 15, 2006
Determination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phasesJane A Sellers, Bernard A Olsen, Paul K Owens, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2016
Formation of copper(I) from trace levels of copper(II) as an artifactual impurity in the HPLC analysis of olanzapineSteven W Baertschi, Bernard A Olsen, Timothy J Wozniak, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2009
A simple and efficient approach to reversed-phase HPLC method screeningKallol M Biswas, Bryan C Castle, Bernard A Olsen, et al.
Talanta|April 21, 2009
A new statistical method for the automated detection of peaks in UV-DAD chromatograms of a sample mixtureBenjamin Debrus, Pierre Lebrun, Attilio Ceccato, et al.
Pageof 1